TAG:
managed care contract
Lab Director Takes a Stand On Patented Genetic Testing
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
THIS LETTER APPEARED in the mailbag after our special intelligence briefing on how genetics will transform healthcare and before our look at how high-priced specialty esoteric testing is causing budget headaches for regional labs. (See TDRs, December 30, 2002 and …
Quest Finally Owns Unilab, New Market Cycle To Begin
By Robert Michel | From the Volume X No. 3 – March 3, 2003 Issue
PERSISTENCE FINALLY PAID OFF for Quest Diagnostics Incorporated. On February 26, it took ownership of Unilab Corporation, capping almost 11 months of effort. In completing this acquisition, Quest Diagnostics completes the two blood brothers’ acquisition sweep of m…
LabCorp Starts Tinkering With DIANON Systems
By Robert Michel | From the Volume X No. 2 – February 10, 2003 Issue
CEO SUMMARY: For almost two decades, DIANON Systems supported one of the most successful sales and marketing programs in the public laboratory sector. However, despite its pre-acquisition statements that it would retain DIANON’s operational integrity, LabCorp has already begun to implem…
Why There’s “Bad Blood” Against National Labs
By R. Lewis Dark | From the Volume X No. 1 – January 20, 2003 Issue
I AM FREQUENTLY ASKED BY WALL STREET TYPES why there seems to be latent, even deep-seated animosity between a large number of local laboratories and both of the two blood brothers. They wonder why, for example, hospital laboratories aren’t more interested in doing collaborative ventures with either…
Several Major Surprises Mark Events of 2002
By Robert Michel | From the Volume IX No. 17 – December 9, 2002 Issue
CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management syst…
Another Lab Acquisition: LabCorp To Buy DIANON
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national…
Why DIANON Sale Alters Anatomic Path Market
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
Why Do Michigan Hospital Labs “Have it Together?
By R. Lewis Dark | From the Volume IX No. 15 – October 28, 2002 Issue
WHAT MAKES HOSPITAL LABORATORY ADMINISTRATORS AND PATHOLOGISTS in Michigan so willing to be both innovative and collaborative in creating sophisticated and financially successful regional laboratory organizations? As you will read on pages 2-6, Michigan Co-Tenancy Laboratory (MCL), …
Changes Expected in Market For Hospital Reference Testing
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: For the hospital send-out testing marketplace, 2002 has been an eventful year. First came the acquisition of American Medical Laboratories by Quest Diagnostics Incorporated. In April, Specialty Laboratories disclosed its problems with state and federal laboratory regulators. …
Two Blood Brothers Use “Free Testing” Strategy
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a business strategy that Quest Diagnostics Incorporated and Laboratory Corporation of America use in selected areas where they have lost exclusive managed care contracts to regional lab competitors. In order to retain access to a physician’s fee-for-service testing b…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized